ARTICLE | Company News

Teva sales and marketing update

September 15, 2014 7:00 AM UTC

Teva launched a generic version of 0.5 and 1 mg Baraclude entecavir in the U.S. Teva said it will have 180 days of generic market exclusivity for the product and declined to disclose pricing. Bristo...